Stomach cancer enzyme

Our researchers in the Japanese city of Nagoya discovered an enzyme against stomach cancer.

The malignant tumors of the stomach are mostly adenocarcinomas. Only around four to five percent of cases are neuroendocrine tumors (NET) and gastrointestinal stromal tumors, with a higher proportion affecting women. In every sixth affected woman and every third affected man, the tumors are located at the stomach entrance (cardia).

With increasing age, the risk of developing gastric cancer increases in both sexes. On average, men come down with stomach cancer at the age of 72, and women four years later. The relative five-year survival rate for women is 34 percent and for men it is 32 percent. In other words, compared to other types of cancer, it has remained rather unfavorable, despite the better chance of survival in recent years. In cases with sufficient documentation of the tumor stage, around a third of the cases had the tumor already metastasized at diagnosis (stage IV).

We recommend taking one capsule three times a day.